Sorry, you need to enable JavaScript to visit this website.

Our Policies on Ethics

As we work to develop new medicines, our strict standards of moral and ethical conduct are guided by the help and oversight of institutional review boards, regulatory authorities, and industry association guidelines governing ethical clinical trial conduct and research integrity. Additionally, we have created our own agency to oversee our research ethics and integrity. 

All Pfizer-sponsored interventional studies are conducted in accordance with applicable laws and regulations, as well as principles derived from relevant international standards including: 

  • The Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines 

  • The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 guideline for Good Clinical Practice 

  • PhRMA’s Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results 

  • The Declaration of Helsinki 

  • The United States Belmont report 

We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving priorities.

Related Articles

Podcast Highlights Pfizer Foundation’s Mission to Improve Breast Cancer Outcomes

For over 75 years, the Pfizer Foundation, a charitable organization, has worked toward the mission of helping build healthier communities around the world.

Event graphic with three speaker headshots on a dark blue global-themed background thumbnail

Science & Innovation

Not Quite Out of the Woods: Risk for Lyme Disease Prevails in Suburban Environments

Encounters with infected ticks that can cause Lyme disease can happen doing routine activities around the yard, and common outdoor activities in your everyday life can put you at heightened risk for tick bites and, in turn, contracting Lyme disease.

Upfront boy playing in backyard with dog thumbnail

What is Non-Muscle Invasive Bladder Cancer?

According to recent research, bladder cancer is the 12th most common type of cancer worldwide. Of these cases, doctors stage (referring to the process of how far the cancer has progressed) about 75% as non-muscle invasive bladder cancer (NMIBC).

Bladder cancer image

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site Details